Abstract
The concentration of cytokines such as Interleukin-6 (IL-6) has been reported to be elevated in depressed and schizophrenic patients and, in healthy persons, upon stress. Interleukin-6 plasma levels were determined in depressed (n = 12) and schizophrenic (n = 32) patients during the acute state of illness and after remission at approximately 8 weeks after admission and were compared with healthy controls (n = 12). Patients were diagnosed according to DSM-III-R by the Structured Clinical Interview (SLID). Severity of illness was assessed for depression by the Montgomery Asberg Depression Rating Scale (MADRS) and for schizophrenia by the Brief Psychiatric Rating Scale (BPRS). Interleukin-6 plasma concentrations were elevated during the acute state either of depression or of schizophrenia if compared to controls. After remission, IL-6 concentrations in depressed and in schizophrenic patients had decreased and did not differ significantly from controls. We hypothesize that the elevated IL-6 levels during the acute state of depression or schizophrenia may reflect an unspecific stress response.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aarden LA, de Groot ER, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411–1416
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R), 3rd edn, revised. American Psychiatric Press, Washington DC
Barak V, Barak Y, Levine J, Nisman B, Roisman I (1995) Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. J Basic Clin Physiol Pharmacol 6:61–69
Bauer J, Ganter U, Strauss S, Stadtmüller G, Frommberger U, Bauer H, Volk B, Berger M (1992) The participation of interleukin-6 in the pathogenesis of Alzheimer’s disease. Res Immunol 143:650–656
Bauer J, Hohagen F, Ebert T, Timmer J, Ganter U, Krieger S, Lis S, Postler E, Voderholzer U, Berger M (1994) Interleukin-6 serum levels in healthy persons correspond to the sleep-wake cycle. Clin Investig 72:315
Black PH (1994) Central nervous system-immune system interactions: psychoneuroendocrinology of stress and its immune consequences. Antimicrob Agents Chemother 38:1–6
Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L (1993) Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 90:10061–10065
De Rijk RH, Boelen A, Tilders FJH, Berkenbosch F (1994) Induction of plasma interleukin-6 by circulating adrenaline in the rat. Psychoneuroendocrinology 19:155–163
Ganguli R, Yang Z, Shurin G, Chengappa KNR, Brar JS, Gubbi AV, Rabin BS (1994) Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 51:1–10
Hornig-Rohan M, van Bell CT, Kuhn P, Amsterdam JD (1995) Acute phase proteins in affective illness. Biol Psychiatry 37:607 (Abstract)
Joyce P, Hawes C, Mulder R, Sellman J, Wilson D, Boswell D (1992) Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 32:1035–1041
Katila H, Appelberg B, Hurme M, Rimon R (1994) Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr Res 12:29–34
Kushner I (1991) The acute phase response: from Hippocrates to cytokine biology. Eur Cytokine Netw 2:75–80
LeMay LG, Vander AJ, Kluger MJ (1991) The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav 47:957–961
Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P (1993) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 49:11–27
Maes M, Meltzer HY, Bosmans E (1994a) Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1β and IL-6 concentrations. Neuropsychobiology 30:57–60
Maes M, Meltzer HY, Stevens W, Cosyns P, Blockx (1994b) Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal axis in depression. Psychol Med 24:167–177
Maes M, Bosmans E, Calabrese J, Smith R, Meltzer H (1995a) Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 29:141–152
Maes M, Meltzer H, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995b) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34:301–309
Maimone D, Cioni C, Rosa S, Macchia G, Aloisi F, Annunziata P (1993) Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1β and TNFα. J Neuroimmunol 47:73–82
Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389
Müller N (1997) Die Rolle des Zytokinnetzwerks im ZNS und psychische Störungen. Nervenarzt 68:11–20
Norris GJ, Benveniste EN (1993) Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol 45:137–146
Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799–812
Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1995) Cytokine production and serum proteins in depression. Scand J Immunol 41:534–538
Shintani F, Kanba S, Maruo N, Nakaki T, Nibuya M, Suzuki E, Kinoshita N, Yagi G (1991) Serum interleukin-6 in schizophrenic patients. Life Sci 49:661–664
Sluzewska A, Rybakowski J, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762:474–476
Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K (1996) Indicators of immune activation in major depression. Psychiatry Res 64:161–167
Song C, Dinan T, Leonhard B (1994) Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 30:283–288
Spitzer RL, Williams JB, Gibbon M (1987) Structured clinical interview for DSM-111-R (SCID). Biometrics Research Department, New York State Psychiatric Institute, New York
Spivak B, Radwan M, Bartur P, Mester R, Weizman A (1995) Antinuclear autoantibodies in chronic schizophrenia. Acta Psychiatr Scand 92:266–269
Stein TP, Schluter MD (1994) Excretion of IL-6 by astronauts during spaceflight. Am J Physiol 266:E448-E452
Xu HM, Wei J, Hemmings GP (1994) Changes of plasma concentrations of interleukin-lalpha and interleukin-6 with neuroleptic treatment for schizophrenia. Br J Psychiatry 164:251–253
Zhou D, Kusnecov AW, Shurin MR, Paoli M de, Rabin BS (1993) Exposure to physical and psychological stressors elevates plasma interleukin-6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 133:2523–2530
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Frommberger, U.H., Bauer, J., Haselbauer, P. et al. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 247, 228–233 (1997). https://doi.org/10.1007/BF02900219
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02900219